Related Experiment Video
Updated: Dec 18, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Recommendations for the care of patients with heart failure and COVID-19
José A Cigarroa-López1,2,3, José A Magaña-Serrano1,2,3, Amada Álvarez-Sangabriel2,4
1Asociación Nacional de Cardiólogos de México.
Insights
Patients with heart failure (HF) and transplant recipients are at high risk for severe COVID-19 complications. These recommendations guide medical personnel in caring for these vulnerable cardiovascular patients during the pandemic.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic presents significant global health and economic challenges.
- Cardiovascular conditions, particularly heart failure (HF), place patients at higher risk for severe COVID-19 outcomes.
- Immunosuppressed transplant recipients are also highly susceptible to severe infections.
Purpose of the Study:
- To provide recommendations for the medical care of vulnerable cardiovascular patients during the COVID-19 pandemic.
- To address the specific risks faced by patients with heart failure, heart transplants, and pulmonary arterial hypertension.
- To guide healthcare professionals in managing these patients in various clinical settings, regardless of COVID-19 status.
Main Methods:
- Development of clinical recommendations by the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC).
- Consensus-based guidelines drawing on expertise in cardiology and infectious disease management.
- Focus on high-risk patient groups including those with heart failure, ventricular assist devices, heart transplants, and pulmonary arterial hypertension.
Main Results:
- Heart failure is a frequent complication of COVID-19, increasing severity.
- Patients with advanced HF and transplant recipients on immunosuppressants face heightened risks.
- Cardiological symptoms are observed in some COVID-19 patients, indicating complex interactions.
Conclusions:
- Specific guidance is crucial for managing vulnerable cardiovascular patients during the COVID-19 pandemic.
- Proactive care strategies are needed to mitigate risks in heart failure and transplant populations.
- Collaboration between cardiology societies ensures comprehensive recommendations for patient care.
Abstract:
The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some patients also have cardiological symptoms. Among patients with cardiological conditions2 they represent a group of higher risk and, in fact, they are a particularly vulnerable group, due to their higher risk of contagion and greater severity in case of acquiring the disease1 those with heart failure (HF), including heart transplant (CT) and ventricular assists, as well as patients with pulmonary arterial hypertension (PAH). HF is the main chronic cardiovascular disease and patients in this group are the most vulnerable for the development of more serious clinical symptoms after suffering the infection, and to a greater extent cases with advanced HF3. In fact, HF is one of the most frequent complications in patients with COVID-194. Likewise, transplant patients who require immunosuppressants to avoid graft rejection, constitute a population especially susceptible to infection and to develop more serious processes. This situation has made the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC) together with their respective chapters, have prepared the following recommendations for medical personnel, who participate in the care of this special group of patients in the different clinical settings, who suffer or not, of COVID-19.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation IV: Nursing Management

